They proposed that tumor-secreted EVs containing miR-424 suppressed the CD28-CD80/86 co-stimulatory pathway in tumor-infiltrating T cells and dendritic cells, leading to immune checkpoint blockade resistance. Here, CD28 is linked to neoplasm.